1. Home
  2. IBEX vs LXEO Comparison

IBEX vs LXEO Comparison

Compare IBEX & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IBEX Limited

IBEX

IBEX Limited

HOLD

Current Price

$39.47

Market Cap

448.0M

Sector

Technology

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

N/A

Current Price

$4.28

Market Cap

396.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IBEX
LXEO
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
448.0M
396.5M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
IBEX
LXEO
Price
$39.47
$4.28
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
$35.00
$18.44
AVG Volume (30 Days)
93.7K
679.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
28.26
39.81
EPS
2.54
N/A
Revenue
$558,273,000.00
$654,000.00
Revenue This Year
$14.13
N/A
Revenue Next Year
$5.68
N/A
P/E Ratio
$14.58
N/A
Revenue Growth
9.77
N/A
52 Week Low
$25.94
$3.99
52 Week High
$42.99
$10.99

Technical Indicators

Market Signals
Indicator
IBEX
LXEO
Relative Strength Index (RSI) 52.35 39.07
Support Level $36.51 $4.01
Resistance Level $39.81 $5.38
Average True Range (ATR) 1.05 0.24
MACD -0.15 -0.06
Stochastic Oscillator 32.99 5.59

Price Performance

Historical Comparison
IBEX
LXEO

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: